MDLinx Endocrinology Overview: Our medical editors have ranked and organized papers in the top peer-reviewed clinical journals by topic including diabetes types 1 and 2, thyroid and glandular diseases, obesity and dyslipidemia. In a matter of minutes, you and all the members of your patient care team can stay current on the literature as it is published.
Also on this page: MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD, and clinical pearls from The Smartest Diabetes Expert as well as endocrinology topics in The Smartest Internist, The Smartest Family Physician, and The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Endocrinology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Diabetes is not a risk factor for HCC
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Thyroid Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
821 Sperm retrieval in anejaculatory diabetic men who failed in drug treatment and penile vibratory stimulation during blood sugar under control Andrologia, March 14, 2013 Clinical Article
822 Type 2 diabetes in Mauritania: Prevalence of the undiagnosed diabetes, influence of family history and maternal effect Primary Care Diabetes, March 14, 2013 Clinical Article
823 Latent autoimmune diabetes (LADA) is perched between type 1 and type 2: evidence from adults in one region of Spain Diabetes/Metabolism Research and Reviews, March 14, 2013 Clinical Article
824 Baseline HbA1c predicts attainment of 7.0% HbA1c target with structured titration of insulin glargine in type 2 diabetes: a patient-level analysis of 12 studies Diabetes, Obesity and Metabolism, March 13, 2013 Clinical Article
825 Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial The Lancet, March 13, 2013 Clinical Article
826 Health care providers' perspective on using family history in the prevention of type 2 diabetes: a qualitative study including different disciplines Full Text BMC Family Practice, March 13, 2013 Review Article
827 Association of Smoking Cessation and Weight Change With Cardiovascular Disease Among Adults With and Without Diabetes JAMA, March 13, 2013 Clinical Article
828 The use of U-500 regular insulin in the management of patients with obesity and insulin resistance Diabetes, Obesity and Metabolism, March 13, 2013 Clinical Article
829 Efficacy of α-glucosidase inhibitors combined with dipeptidyl-peptidase-4 inhibitor (alogliptin) for glucose fluctuation in patients with type 2 diabetes mellitus by continuous glucose monitoring Journal of Diabetes Investigation, March 13, 2013 Clinical Article
830 Screening, evaluation and management of depression in people with diabetes in primary care Primary Care Diabetes, March 13, 2013 Review Article
831 Ginkgo biloba Extract for Patients with Early Diabetic Nephropathy: A Systematic Review Full Text Evidence-based Complementary and Alternative Medicine , March 13, 2013 Evidence Based Medicine Review Article
832 Metabolic Syndrome And Periodontitis In Gullah African Americans With Type 2 Diabetes Mellitus Journal of Clinical Periodontology, March 13, 2013 Clinical Article
833 The Relationship between Major Depression and Insulin Resistance: Does It Vary by Gender or Race/Ethnicity among Young Adults Aged 20-39 Years? Journal of Diabetes, March 13, 2013 Clinical Article
834 Association of DiGeorge anomaly and caudal dysplasia sequence in a neonate born to a diabetic mother Cardiology in the Young, March 13, 2013 Clinical Article
835 Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health Diabetologia - Clinical and Experimental Diabetes and Metabolism, March 13, 2013 Clinical Article
836 Acromegaly Has a Negative Influence on Trabecular Bone, But Not on Cortical Bone, as Assessed by High-Resolution Peripheral Quantitative Computed Tomography Journal of Clinical Endocrinology and Metabolism, March 13, 2013 Review Article
837 The cost of treating to target: cross-sectional analysis of patients with poorly controlled type 2 diabetes in Australian general practice Full Text BMC Family Practice, March 13, 2013 Clinical Article
838 The prevalence and risk factors of vertebral fractures in Korean patients with type 2 diabetes Journal of Bone and Mineral Metabolism, March 13, 2013 Clinical Article
839 Clinical and functional characterization of the Pro1198Leu ABCC8 gene mutation associated with permanent neonatal diabetes mellitus Journal of Diabetes Investigation, March 13, 2013
840 Sex-specific relationships between insulin resistance and bone mineral content in Korean adolescents Journal of Bone and Mineral Metabolism, March 13, 2013 Clinical Article
As published in Pancreas, researchers at the Bowman Gray School of Medicine have identified a protein (islet homeostasis protein [IHoP]) which appears to control blood glucose levels by regulating the balance between insulin and glucagon. IHoP is released from glucagon-producing cells in the islets. In both humans and animals, high levels of IHoP exist in the euglycemic state, while T1DM is associated with an absence of IHoP. The authors suggest that IHoP may serve as a target in the treatment of T1DM.
Read the article summaryAs reported in the Archives of Internal Medicine, researchers at the Mayo Clinic have shown an association between statin use and diabetes mellitus in postmenopausal women. The study involved 161,808 postmenopausal women (age range, 50-79 years) who were enrolled at 40 centers between 1993 and 1998 as part of the Women’s Health Initiative. Of the study cohort, data was available for 153,840 women without diabetes at baseline, 7.04% of whom used statins. There were 10,242 incident cases of diabetes in statin users (HR = 1.71) during 1,004,466 person-years of follow-up
Read the article summaryAnthropometric, laboratory, and clinical findings were evaluated in 681 patients with type 2 diabetes mellitus to determine the factors with the greatest influence on determining the basal insulin dosage for a target glucose level < 120 mg/dL. The authors reported that waist circumference, the duration of insulin treatment, lipid-lowering medications, use of insulin sensitizers, the HbA1c, fasting plasma glucose, HDL-C, and triglycerides levels, and severe NAFLD were most significant.
Read the article summaryIndexed Journals in Endocrinology: Endocrinology, Journal of Endocrinology, Clinical Endocrinology, Diabetes more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close